Document Type
Article
Publication Date
1996
Abstract
Considers the implications of privatizing the Food and Drug Administration's (FDA) review of the safety and efficacy of medical devices and drugs. Concludes that the FDA's flaws - namely, a risk avoidance culture and autocratic style of regulation - can only be accomplished by breaking the agency's monopolization of this review function.
Recommended Citation
Elizabeth Price Foley and Elizabeth C. Price,
Teaching the Elephant to Dance: Privatizing the FDA Review Process
, 51 Food & Drug L.J. 651
(1996).
Available at: https://ecollections.law.fiu.edu/faculty_publications/419
